FDAnews Drug Daily Bulletin

Pfizer Sues Alembic Over Lyrica ANDA

Dec. 12, 2011
A A
Pfizer and Northwestern University launched a suit in Delaware federal court accusing Alembic of infringing a patent for nerve pain drug Lyrica by seeking approval to sell a generic version of the drug.
Law360